Senores Pharma to acquire 14 ANDAs from Dr Reddy's Laboratories

Senores Pharmaceuticals of Gujarat has signed an agreement to acquire 14 Abbreviated New Drug Applications from Dr Reddy's Laboratories. The acquisition, funded through IPO proceeds, includes 13 USFDA-approved ANDAs. This expands Senores' product offerings in the US and other regulated markets, addressing an opportunity worth USD 421 million.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/i2asevg
via IFTTT